Immunocore Limited announced that Dr. Eliot Forster has stepped down as Chief Executive Officer. Forster informed the Board and will be replaced, in an interim capacity, by Chief Commercial Officer Andrew Hotchkiss.  Eliot will continue to work with Andrew. Andrew joined Immunocore as Chief Commercial Officer in 2017. In his new role as CEO, he will also sit on the Immunocore Board.